Indefinite Delivery Contract SPE2DX15D9700
- Not listed
- The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract, SPE2DB, to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $499,999,999, has a period of performance through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. The products include flumazenil...
- This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a potential value of up to $4,999,999 and runs through December 2025. Under this contract, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans'...
- This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The single-award contract has a potential value up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide. This includes drugs and products such as flumazenil injection, prednisone...
- The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
- This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award contract, valued up to $4,999,999, allows the DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. Through this contract, DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a for-profit woman-owned small business, was awarded a single-award indefinite delivery contract (IDC) by the Defense Logistics Agency (DLA) valued up to $4,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. The contract covers a diverse...
- The Defense Logistics Agency has awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a variety of pharmaceutical and medical supplies. The single-award contract has a potential value of up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will deliver pharmaceutical items such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a single-award Indefinite Delivery Contract (SPE2DX) by the Defense Logistics Agency's Medical Supply Chain division on July 8, 2025, with a contract ceiling of $4,999,999.00 and an ultimate completion date of December 31, 2026. The contract provides firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, under the SPE2DB program, provides the DLA with firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The products covered include branded...
The indefinite delivery contract SPE2DX15D9700 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award contract has a ceiling value of $4,999,999.00 and runs through November 12, 2025. Under this contract, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The product offerings include branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. These products are primarily delivered to the DLA's Medical Supply Chain division, which then distributes them to various Department of Defense (DoD) healthcare facilities globally. The contract leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Change Order | $0 | 5/21/24 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 9/11/20 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 8/30/18 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 8/29/17 | |
| Not listed | Not listed | $0 | 3/5/15 |